“…ENUmutagenesis programs have proven to be a highly valuable approach in identifying novel mutations and genes involved in the auditory pathway, as well as revealing novel functions of genes already known to be involved in hearing (Curtin et al, 2003;Hardisty et al, 2003;Hrabe de Angelis et al, 2000;Kiernan et al, 2001;Marcotti et al, 2006;Nolan et al, 2000;Rhodes et al, 2004Rhodes et al, , 2003Tsai et al, 2001;Vreugde et al, 2002). Initially, ENUmutagenesis programs focused on dominant disease-causing mutations, however, as the majority of human genetic deafness is recessively inherited, characterisation of recessive ENU-mutants, such as charlie, will be essential for gaining further insight into the development and functioning of the mammalian auditory system (Kermany et al, 2006;Manji et al, 2012Manji et al, , 2011a2011b;Parker et al, 2010). Given the high degree of similarity between the mouse and human inner ear, and the conserved role of Myo6 in the mammalian inner ear, charlie will be a valuable resource for gaining a more thorough understanding of the role Myo6 plays in hearing and balance, and may ultimately help to guide therapeutic approaches for patients with deafness attributable to Myo6 mutations.…”